Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1988 1
1989 1
1990 1
1992 2
1993 5
1994 5
1995 2
1996 4
1997 2
1998 5
1999 3
2000 1
2002 2
2003 3
2004 4
2005 4
2006 5
2007 8
2008 14
2009 7
2010 4
2011 8
2012 5
2013 2
2014 2
2015 3
2016 4
2017 4
2018 4
2019 5
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19616703

121 results

Results by year

Filters applied: . Clear all
Page 1
Phase 0 trials: a platform for drug development?
[No authors listed] [No authors listed] Lancet. 2009 Jul 18;374(9685):176. doi: 10.1016/S0140-6736(09)61309-X. Lancet. 2009. PMID: 19616703 No abstract available.
The exploratory IND.
Mills G. Mills G. J Nucl Med. 2008 Jun;49(6):45N-47N. J Nucl Med. 2008. PMID: 18511824 Free article. No abstract available.
Regulatory considerations for preclinical development of anticancer drugs.
DeGeorge JJ, Ahn CH, Andrews PA, Brower ME, Giorgio DW, Goheer MA, Lee-Ham DY, McGuinn WD, Schmidt W, Sun CJ, Tripathi SC. DeGeorge JJ, et al. Cancer Chemother Pharmacol. 1998;41(3):173-85. doi: 10.1007/s002800050726. Cancer Chemother Pharmacol. 1998. PMID: 9443633 Review.
The do's and don'ts of preclinical development.
Graffeo A. Graffeo A. Biotechnology (N Y). 1994 Sep;12(9):865-9. doi: 10.1038/nbt0994-865. Biotechnology (N Y). 1994. PMID: 7765226 No abstract available.
121 results